KPRX Kiora Pharmaceuticals, Inc. - Common Stock
$2,54
Cena · Sie 18, 2026
Dane fundamentalne na dzień Sie 7, 2026
Zakres 52 tyg.
$2–$3
65% of range
Ocena Analityków
BUY
7 analysts
Cena Docelowa
$12
+372% upside
P/E (TTM)
-1.0
ROE
-56.6%
Marża Zysku Netto
—
KPRX Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$2.54
Kapitalizacja Rynkowa
$10M
P/E (TTM)
-1.0
EPS (TTM)
$-2.64
Przychody (TTM)
$0
Stopa dywidendy
—
ROE
-56.6%
D/E Dług/Kapitał
—
Zakres 52 tyg.
$2 – $3
KPRX Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
Configure
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody i Zysk Netto
$0
2016-12-31
→
2025-12-31
EPS
$-2.64
2020-12-31
→
2025-12-31
Wolny przepływ pieniężny
$-10M
2017-12-31
→
2025-12-31
Marże
—
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
Wskaźnik
Trend 5-letni
KPRX
Mediana porównawcza
P/E (TTM)
-1.0
44.2
P/B
0.6
2.1
Price / FCF (Cena / FCF)
-0.9
—
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
Wskaźnik
Trend 5-letni
KPRX
Mediana porównawcza
ROA
-35.7%
-49.9%
ROE
-56.6%
-51.4%
ROIC
-71.2%
—
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
Wskaźnik
Trend 5-letni
KPRX
Mediana porównawcza
Current Ratio (Wskaźnik bieżący)
6.0
3.7
Quick Ratio (Wskaźnik Szybkości)
5.1
—
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
Wskaźnik
Trend 5-letni
KPRX
Mediana porównawcza
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
Wskaźnik
Trend 5-letni
KPRX
Mediana porównawcza
KPRX Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
KUP
7 analityków
- Mocne kupno 2 28,6%
- Kup 4 57,1%
- Trzymaj 1 14,3%
- Sprzedaj 0 0,0%
- Mocna sprzedaż 0 0,0%
12-miesięczny cel cenowy
1 analityków · 2026-08-15
Niski
$12.00
Wysoki
$12.00
Średni cel
$12.00
+372,4%
Średnia cel
$12.00
+372,4%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.01%
| Okres | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|
| 30 czerwca 2026 | $-0.34 | $-0.63 | 0.29% |
| 31 marca 2026 | $-0.58 | $-0.72 | 0.14% |
| 31 grudnia 2025 | $-1.59 | $-0.68 | -0.91% |
| 30 września 2025 | $0.01 | $-0.75 | 0.76% |
| 30 czerwca 2025 | $-0.54 | $-0.62 | 0.08% |
| 31 marca 2025 | $-0.52 | $-0.68 | 0.16% |
| 31 grudnia 2024 | $-1.04 | $-0.56 | -0.48% |
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| KPRX | $7M | -0.7 | — | — | -56.6% | — |
| COCP | $14M | -1.3 | — | — | -151.4% | — |
| HIND | $20M | -0.7 | 24.4% | -3209.7% | -411.1% | 68.4% |
| DARE | $28M | -1.6 | 10429.4% | -1300.7% | 270.9% | — |
| ADIL | $244.4K | -0.0 | — | — | -146.8% | — |
| TRAW | — | 1.4 | 1134.5% | — | — | — |
| CNSP | — | -0.1 | — | — | — | — |
| LLY | — | 46.8 | 44.7% | 31.7% | 101.2% | — |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat 16
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $16M | $0 | · | $0 | $12.1K | $3M | $2M | $407.5K | $669.3K | $0 | |
| R&D Expense | $11M | $8M | $4M | $3M | $5M | $4M | $5M | $8M | $10M | $8M | $3M | |
| SG&A Expense | $6M | $6M | $5M | $8M | $5M | $5M | $4M | $4M | $5M | $6M | $4M | |
| Operating Expenses | $13M | $12M | $13M | $12M | $14M | $7M | $10M | $12M | $15M | $14M | $7M | |
| Operating Income | $-13M | $5M | $-13M | $-12M | $-14M | $-7M | · | $-11M | · | · | · | |
| Interest Expense | · | · | $11.1K | $8.6K | $6.9K | $4.2K | $325 | $1.0K | $1.2K | $275 | $2M | |
| Interest Income | $894.0K | $1M | $174.0K | $56.9K | $1.1K | $23.3K | $108.1K | $120.4K | $564 | $3.7K | $947 | |
| Other Non-op | $-160.3K | $26.1K | $28.8K | $-14.5K | $272.5K | $19.2K | $107.7K | $119.3K | $-651 | $3.4K | $10 | |
| Pretax Income | $-12M | $6M | $-12M | $-14M | $-14M | $-7M | $-7M | $-11M | $-15M | $-13M | $-8M | |
| Income Tax | $-1M | $2M | $90.3K | $-113.0K | $-192.6K | $12.1K | $95.4K | $86.0K | $-1M | $0 | · | |
| Net Income | $-11M | $4M | $-13M | $-14M | $-14M | $-7M | $-7M | $-11M | $-13M | $-13M | $-8M | |
| EPS (Basic) | $-2.60 | $0.93 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · | |
| EPS (Diluted) | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 | $-1.49 | · | · | · | · | · | |
| Shares (Basic) | 4,166,692 | 3,872,644 | 538,007 | 732,303 | 241,099 | 4,591,491 | · | · | · | · | · | |
| Shares (Diluted) | 4,103,873 | 4,125,075 | 538,007 | 732,303 | 241,099 | 4,591,491 | · | · | · | · | · | |
| EBITDA | $-13M | $5M | $-13M | $-12M | $-14M | $33.4K | $51.7K | $-11M | $19.3K | $5.2K | $1.3K |
Bilans 27
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $9M | $4M | $2M | $6M | $8M | $1M | $4M | $8M | $8M | $4M | $8M | |
| Short-term Investments | $8M | $23M | $0 | · | · | · | · | · | · | · | · | |
| Receivables | $2M | $601.2K | $0 | · | · | · | · | · | · | · | · | |
| Prepaid Expense | $1M | $2M | $233.4K | $343.1K | $606.5K | $449.6K | $458.8K | $455.8K | $629.6K | $465.0K | $122.4K | |
| Current Assets | $22M | $30M | $5M | $8M | $9M | $2M | $4M | $8M | $8M | $4M | $9M | |
| PP&E (Net) | $91.7K | $5.2K | $8.1K | $55.2K | $74.0K | $30.6K | $16.8K | $43.5K | $55.8K | $38.0K | $0 | |
| PP&E (Gross) | $117.6K | $6.3K | $14.4K | $172.5K | $187.1K | $123.5K | $99.6K | $99.6K | $79.6K | $42.6K | $268.1K | |
| Accum. Depreciation | $25.9K | $1.0K | $6.3K | $117.3K | $113.1K | $93.0K | $82.7K | $56.1K | $23.8K | $4.5K | $268.1K | |
| Goodwill | · | · | · | $0 | $0 | $4M | $2M | $2M | $2M | · | · | |
| Intangibles | $2M | $7M | $9M | $11M | $11M | $10M | $4M | $4M | $4M | · | · | |
| Other Non-current Assets | $59.7K | $24.9K | $40.8K | $33.0K | $43.0K | $57.1K | $69.4K | $31.7K | $307.1K | $55.3K | $38.6K | |
| Total Assets | $24M | $36M | $14M | $19M | $20M | $15M | $10M | $14M | $14M | $10M | $10M | |
| Accounts Payable | $1M | $415.6K | $206.3K | $1M | $160.6K | $434.8K | $210.3K | $63.7K | $706.1K | $1M | $417.7K | |
| Accrued Liabilities | $2M | $5M | $1M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | |
| Short-term Debt | · | · | · | · | · | $212.3K | · | · | · | · | · | |
| Current Liabilities | $4M | $6M | $2M | $3M | $2M | $2M | $1M | $4M | $15M | $7M | $3M | |
| Capital Leases | $203.8K | $33.8K | $59.8K | $0 | $90.6K | $35.6K | $0 | $0 | $4.9K | $16.1K | $0 | |
| Deferred Tax | $102.2K | $490.7K | $779.4K | $689.1K | $802.1K | $728.9K | $365.4K | $270.0K | $183.9K | $2M | $0 | |
| Total Liabilities | $8M | $11M | $8M | $7M | $6M | $6M | $3M | $5M | $16M | $10M | $3M | |
| Total Debt | · | · | · | · | · | $278.2K | · | · | · | · | · | |
| Common Stock | $275.3K | $267.7K | $77.1K | $18.0K | $3.2K | $55.6K | $40.8K | $30.4K | $172.6K | $101.3K | $76.6K | |
| Paid-in Capital | $170M | $169M | $153M | $146M | $136M | $117M | $107M | $102M | $90M | $78M | $71M | |
| Retained Earnings | $-154M | $-143M | $-147M | $-134M | $-121M | $-107M | $-100M | $-93M | $-92M | $-79M | $-65M | |
| AOCI | $-246.1K | $-282.2K | $-182.8K | $-182.7K | $-86.4K | $-802 | $139.5K | $134.3K | $127.5K | $120.2K | $114.8K | |
| Stockholders' Equity | $16M | $26M | $6M | $11M | $15M | $10M | $7M | $9M | $-2M | $-329.4K | $6M | |
| Liabilities + Equity | $24M | $36M | $14M | $19M | $20M | $15M | $10M | $14M | $14M | $10M | $10M | |
| Shares Outstanding | 3,761,739 | 3,000,788 | 856,182 | 1,796,472 | 316,599 | 5,556,394 | 4,077,755 | 3,038,592 | 17,257,255 | 10,130,883 | 7,657,287 |
Przepływy pieniężne 17
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $24.8K | $19.2K | $51.8K | $41.6K | $45.3K | $33.4K | $51.7K | $38.5K | $19.3K | $5.2K | $1.3K | |
| Stock-based Comp | $900.2K | $656.6K | $754.9K | $462.4K | $842.5K | $723.9K | $852.2K | $875.3K | $870.3K | $511.0K | $1M | |
| Deferred Tax | · | · | $90.3K | $-113.0K | $-192.6K | $-12.1K | $-95.4K | $-86.0K | $1M | $0 | · | |
| Amort. of Intangibles | $0 | $15.0K | $25.0K | $25.0K | $25.0K | $25.0K | $25.0K | $6.2K | $0 | · | · | |
| Other Non-cash | $-51.1K | $4M | $2M | $3M | $2M | $29.6K | $-2M | $-860.8K | $7M | $4M | $3M | |
| Operating Cash Flow | $-10M | $9M | $-10M | $-10M | $-11M | $-7M | $-8M | $-11M | $-6M | $-8M | $-4M | |
| CapEx | $110.8K | $6.3K | $0 | $0 | $63.9K | $20.1K | $0 | $20.0K | $37.0K | $0 | · | |
| Investing Cash Flow | $14M | $-23M | $0 | $6.4K | $-157.0K | $-244.4K | $0 | $-270.0K | $-37.0K | $174.7K | · | |
| Debt Issued | · | · | · | · | $0 | $278.2K | $0 | · | · | · | · | |
| Net Debt Issued | · | · | · | · | $0 | $278.2K | · | · | · | · | · | |
| Stock Issued | · | · | · | $5M | $18M | $5M | $2M | $10M | $11M | $4M | $14M | |
| Net Stock Activity | · | · | · | $5M | $19M | $5M | $2M | $10M | $12M | $4M | · | |
| Financing Cash Flow | $265.7K | $15M | $6M | $9M | $18M | $5M | $4M | $11M | $11M | $3M | · | |
| Net Change in Cash | $5M | $1M | $-4M | $-2M | $7M | $-3M | $-4M | $198.2K | $4M | $-5M | $8M | |
| Taxes Paid | $2M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $-10M | $9M | · | $-10M | $-11M | $-7M | · | $-11M | $-7M | · | · | |
| Levered FCF | · | · | · | $-10M | $-11M | $-7M | · | $-11M | $-7M | · | · |
Rentowność 7
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | 28.1% | · | · | · | · | · | -656.2% | · | · | · | |
| Net Margin | · | 22.4% | · | · | · | -67102.9% | -264.2% | -654.2% | -3243.5% | -1993.8% | · | |
| Pretax Margin | · | 35.3% | · | · | · | -67002.9% | -260.7% | -649.0% | -3572.8% | -1993.8% | · | |
| EBITDA Margin | · | 28.3% | · | · | · | 277.0% | 1.9% | -653.9% | 4.7% | 0.77% | · | |
| ROA | -35.7% | 14.3% | -77.3% | -70.0% | -77.7% | -64.0% | -58.2% | -75.6% | -110.0% | -138.7% | -153.7% | |
| ROE | -56.6% | 12.9% | -176.1% | -123.9% | -78.5% | -124.9% | -119.9% | -107.9% | 1171.6% | -463.5% | 41.2% | |
| ROIC | -71.2% | 11.1% | -207.5% | -107.0% | -96.3% | · | · | -122.3% | · | · | · |
Płynność i wypłacalność 5
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.0 | 4.9 | 2.9 | 2.3 | 5.6 | 1.0 | 3.1 | 2.2 | 0.6 | 0.6 | 2.8 | |
| Quick Ratio | 5.1 | 4.6 | 1.5 | 1.8 | 4.9 | 0.7 | 2.7 | 2.1 | 0.5 | 0.5 | 2.5 | |
| Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | |
| LT Debt / Equity | · | · | · | · | · | 0.0 | · | · | · | · | · | |
| Interest Coverage | · | · | -1130.7 | -1431.5 | -2077.9 | · | · | -10427.6 | · | · | · |
Efektywność 2
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.6 | · | · | 0.0 | 0.0 | 0.2 | 0.1 | 0.0 | 0.1 | · | |
| Receivables Turnover | 0.0 | 53.3 | · | · | · | · | · | · | · | · | · |
Wycena (TTM) 14
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $16M | $0 | $0 | $0 | $12.1K | $3M | $2M | $407.5K | $669.3K | $0 | |
| Net Income TTM | $-11M | $4M | $-13M | $-14M | $-14M | $-7M | $-7M | $-11M | $-13M | $-13M | $-8M | |
| Market Cap | $7M | $10M | $36M | $55M | $6.88B | $9.86B | $14.71B | $109.97B | $99.71B | $89.17B | $113.30B | |
| Enterprise Value | · | · | · | · | · | $9.86B | · | · | · | · | · | |
| P/E | -0.7 | 3.8 | -0.2 | -1.7 | -9.5 | -1191.1 | · | · | · | · | · | |
| P/S | · | 0.6 | · | · | · | 817770.0 | 5476.3 | 66544.7 | 244682.2 | 133239.9 | · | |
| P/B | 0.5 | 0.4 | 5.9 | 4.9 | 472.2 | 1408.9 | 2221.1 | 12305.6 | -51747.0 | -270693.2 | 18613.7 | |
| P / Tangible Book | 0.5 | 0.5 | · | 83.5 | 1806.4 | · | · | · | · | · | · | |
| P / Cash Flow | -0.7 | 1.2 | -3.8 | -5.3 | -644.9 | -1347.7 | -1804.0 | -10140.3 | -15415.0 | -10599.1 | -25407.7 | |
| P / FCF | -0.7 | 1.2 | · | -5.3 | -641.0 | -1344.0 | · | -10121.6 | -15327.3 | · | · | |
| EV / EBITDA | · | · | · | · | · | 295235.8 | · | · | · | · | · | |
| EV / FCF | · | · | · | · | · | -1343.9 | · | · | · | · | · | |
| EV / Revenue | · | · | · | · | · | 817694.7 | · | · | · | · | · | |
| Earnings Yield | -134.0% | 26.4% | -516.2% | -60.1% | -10.5% | -0.08% | · | · | · | · | · |
Rachunek zysków i strat 15
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $20.0K | $16M | $0 | $0 | $0 | $0 | · | · | |
| R&D Expense | $2M | $2M | $3M | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $438.3K | $841.6K | $1M | |
| SG&A Expense | $1M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $1M | $880.5K | $1M | $1M | $1M | $3M | $2M | |
| Operating Expenses | $2M | $3M | $7M | $794.4K | $2M | $2M | $3M | $4M | $3M | $3M | $2M | $6M | $3M | $2M | $3M | $4M | |
| Operating Income | $-2M | $-3M | $-7M | $-794.4K | $-2M | $-2M | $-3M | $-4M | $-3M | $13M | $-2M | $-6M | $-3M | $-2M | $-3M | $-4M | |
| Interest Income | · | · | · | · | $225.2K | $277.3K | · | · | $342.1K | $223.2K | · | · | · | · | · | · | |
| Other Non-op | $-11.5K | $-47.1K | $-26.8K | $-23.7K | $-93.6K | $-16.3K | $96.8K | $-59.9K | $-18.9K | $8.1K | $-65.7K | $105.7K | $-25.9K | $14.7K | $-15.4K | $937 | |
| Pretax Income | $-2M | $-2M | $-7M | $-616.3K | $-2M | $-2M | $-2M | $-3M | $-2M | $13M | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $-650.0K | $-643.1K | $-112.1K | $123.0K | $2M | $0 | $0 | $0 | · | · | · | · | · | · | |
| Net Income | $-2M | $-2M | $-7M | $26.8K | $-2M | $-2M | $-4M | $-3M | $-2M | $13M | $-2M | $-6M | $-3M | $-2M | $-2M | $-5M | |
| EPS (Basic) | $-0.34 | $-0.58 | $-1.55 | $0.01 | $-0.54 | $-0.52 | $-2.40 | $-0.81 | $-0.53 | $4.67 | $-8.80 | $-7.30 | $-7.15 | $-1.00 | $-1.07 | $-6.03 | |
| EPS (Diluted) | $-0.34 | $-0.58 | $-1.59 | $0.01 | $-0.54 | $-0.52 | $-1.25 | $-0.81 | $-0.53 | $3.46 | $-8.80 | $-7.30 | $-7.15 | $-1.00 | $-1.07 | $-6.03 | |
| Shares (Basic) | 6,177,679 | 4,174,802 | -8,329,210 | 4,289,853 | 3,989,042 | 4,217,007 | -7,394,729 | 4,214,950 | 4,170,627 | 2,881,796 | -2,480,645 | 789,656 | 365,530 | 1,863,466 | -13,498,324 | 848,534 | |
| Shares (Diluted) | 6,177,679 | 4,174,802 | -8,463,916 | 4,361,740 | 3,989,042 | 4,217,007 | -8,152,224 | 4,214,950 | 4,170,627 | 3,891,722 | -2,480,645 | 789,656 | 365,530 | 1,863,466 | -13,498,324 | 848,534 | |
| EBITDA | $-2M | $-2M | · | $-794.4K | $-2M | $-2M | · | $-4M | $-3M | $13M | · | $-6M | $-3M | $-2M | · | $-4M |
Bilans 24
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $7M | $11M | $9M | $6M | $1M | $4M | $4M | $6M | $7M | $31M | $2M | $5M | $8M | $3M | $6M | $5M | |
| Short-term Investments | $10M | $3M | $8M | $14M | $20M | $20M | $23M | $23M | $21M | · | $0 | · | · | · | · | · | |
| Receivables | $1M | $2M | $2M | $1M | $2M | $1M | $601.2K | $2M | $1M | $189.9K | $0 | · | · | · | · | · | |
| Prepaid Expense | $1M | $1M | $1M | $650.4K | $957.1K | $941.5K | $2M | $470.4K | $339.6K | $206.7K | $233.4K | $239.4K | $266.5K | $488.9K | $343.1K | $260.0K | |
| Current Assets | $21M | $19M | $22M | $23M | $25M | $27M | $30M | $32M | $32M | $33M | $5M | $7M | $9M | $6M | $8M | $7M | |
| PP&E (Net) | $99.6K | $86.8K | $91.7K | $101.8K | $106.8K | $5.0K | $5.2K | $62.6K | $63.5K | $12.9K | $8.1K | $38.6K | $44.9K | $51.3K | $55.2K | $59.2K | |
| PP&E (Gross) | · | · | $117.6K | · | · | · | $6.3K | · | · | · | $14.4K | · | · | · | $172.5K | · | |
| Accum. Depreciation | · | · | $25.9K | · | · | · | $1.0K | · | · | · | $6.3K | · | · | · | $117.3K | · | |
| Intangibles | $2M | $2M | $2M | $7M | $7M | $7M | $7M | $7M | $9M | $9M | $9M | $9M | $11M | $11M | $11M | $11M | |
| Other Non-current Assets | $85.4K | $88.2K | $59.7K | $58.1K | $61.0K | $64.3K | $24.9K | $29.9K | $32.1K | $39.4K | $40.8K | $32.0K | $32.4K | $32.7K | $33.0K | $33.0K | |
| Total Assets | $24M | $21M | $24M | $30M | $32M | $34M | $36M | $39M | $41M | $42M | $14M | $16M | $20M | $17M | $19M | $18M | |
| Accounts Payable | $216.5K | $594.9K | $1M | $241.5K | $282.5K | $942.5K | $415.6K | $660.4K | $268.6K | $323.1K | $206.3K | $125.4K | $131.3K | $587.5K | $1M | $749.2K | |
| Accrued Liabilities | $2M | $2M | $2M | $2M | $3M | $4M | $5M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $2M | $2M | |
| Current Liabilities | $2M | $3M | $4M | $3M | $3M | $5M | $6M | $4M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | |
| Capital Leases | $160.6K | $195.4K | $203.8K | $248.2K | $287.1K | $87.5K | $33.8K | $39.2K | $40.2K | $46.4K | $59.8K | $0 | $0 | $0 | $0 | $4.8K | |
| Deferred Tax | $102.2K | $102.2K | $102.2K | $490.7K | $490.7K | $490.7K | $490.7K | $779.4K | $779.4K | $779.4K | $779.4K | $689.1K | $689.1K | $689.1K | $689.1K | $802.1K | |
| Total Liabilities | $7M | $7M | $8M | $7M | $10M | $10M | $11M | $8M | $8M | $8M | $8M | $8M | $6M | $6M | $7M | $7M | |
| Common Stock | $281.9K | $277.6K | $275.3K | $272.0K | $272.0K | $267.7K | $267.7K | $267.7K | $267.4K | $262.6K | $77.1K | $76.9K | $69.1K | $19.2K | $18.0K | $10.8K | |
| Paid-in Capital | $176M | $171M | $170M | $170M | $170M | $169M | $169M | $169M | $169M | $168M | $153M | $153M | $153M | $147M | $146M | $143M | |
| Retained Earnings | $-159M | $-157M | $-154M | $-148M | $-148M | $-146M | $-143M | $-139M | $-136M | $-134M | $-147M | $-145M | $-139M | $-136M | $-134M | $-132M | |
| AOCI | $-255.8K | $-228.8K | $-246.1K | $-243.7K | $-245.8K | $-297.2K | $-282.2K | $-75.2K | $-245.7K | $-264.4K | $-182.8K | $-266.2K | $-225.9K | $-215.4K | $-182.7K | $-263.4K | |
| Stockholders' Equity | $17M | $14M | $16M | $22M | $22M | $24M | $26M | $30M | $33M | $35M | $6M | $8M | $14M | $10M | $11M | $11M | |
| Liabilities + Equity | $24M | $21M | $24M | $30M | $32M | $34M | $36M | $39M | $41M | $42M | $14M | $16M | $20M | $17M | $19M | $18M | |
| Shares Outstanding | 4,427,167 | 3,993,469 | 3,761,739 | 3,433,491 | 3,433,491 | 3,000,788 | 3,000,788 | 3,000,788 | 2,970,545 | 26,256,197 | 856,182 | 7,689,240 | 6,910,720 | 1,919,270 | 1,796,472 | 1,079,045 |
Przepływy pieniężne 11
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10.7K | $10.6K | $10.5K | $10.6K | $3.4K | $318 | $5.9K | $2.1K | $6.3K | $4.9K | $7.9K | $11.3K | $22.5K | $10.1K | $10.3K | $10.3K | |
| Stock-based Comp | $109.3K | $209.5K | $234.4K | $254.4K | $262.8K | $148.6K | $160.2K | $171.2K | $149.8K | $175.4K | $182.3K | $264.9K | $171.8K | $135.9K | $45.1K | $130.2K | |
| Other Non-cash | · | $-963.4K | · | · | · | $-660.2K | · | · | · | $-8.7K | · | · | · | $-1M | · | · | |
| Operating Cash Flow | $-2M | $-3M | $-2M | $-1M | $-4M | $-3M | $-2M | $920.1K | $-4M | $14M | $-3M | $-3M | $-1M | $-3M | $-2M | $-3M | |
| CapEx | $23.5K | $5.0K | $78.2K | $431 | $32.2K | $0 | $-45.0K | $0 | · | · | $0 | $0 | · | · | · | · | |
| Investing Cash Flow | $-7M | $5M | $5M | $6M | $664.2K | $3M | $482.7K | $-2M | $-21M | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Stock Issued | · | · | · | · | · | · | · | $0 | $0 | $0 | · | $0 | $343.4K | $99.0K | · | $5M | |
| Net Stock Activity | · | · | · | · | · | · | · | · | · | $0 | · | · | · | $99.0K | · | · | |
| Financing Cash Flow | $5M | $-842 | $296 | $0 | $265.4K | $0 | $0 | $0 | $250.5K | $15M | $-486.4K | $0 | $6M | $513.2K | $3M | $5M | |
| Net Change in Cash | $-4M | $2M | $3M | $4M | $-3M | $-21.3K | $-2M | $-938.0K | $-25M | $29M | $-3M | $-3M | $5M | $-3M | $1M | $2M | |
| Free Cash Flow | · | $-3M | · | · | · | · | · | · | · | · | · | · | · | · | · | · |
Rentowność 6
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | · | · | · | -12724.4% | 82.6% | · | -11858.0% | -5839.8% | -5727.4% | · | -47106.4% | |
| Net Margin | · | · | · | · | · | · | · | · | -11108.2% | 84.1% | · | -11546.2% | -5797.3% | -5583.6% | · | -65123.2% | |
| EBITDA Margin | · | · | · | · | · | · | · | · | -12724.4% | 82.7% | · | -11858.0% | -5839.8% | -5697.3% | · | -47106.4% | |
| ROA | -7.5% | -8.8% | · | 0.08% | -5.9% | -5.7% | · | -12.6% | -7.3% | 45.6% | · | -34.4% | -14.8% | -10.9% | · | -23.7% | |
| ROE | -10.7% | -12.8% | · | 0.10% | -7.8% | -7.5% | · | -17.9% | -9.5% | 59.7% | · | -61.9% | -23.3% | -17.4% | · | -36.7% | |
| ROIC | -13.1% | -18.0% | · | 0.15% | -10.3% | -10.4% | · | · | · | · | · | · | · | · | · | · |
Płynność i wypłacalność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 9.0 | 6.7 | · | 8.8 | 7.8 | 5.1 | · | 9.0 | 19.2 | 21.0 | · | 3.3 | 4.8 | 2.6 | · | 2.2 | |
| Quick Ratio | 7.6 | 5.5 | · | 8.0 | 7.2 | 4.8 | · | 8.7 | 17.6 | 19.8 | · | 2.6 | 4.2 | 1.6 | · | 1.6 |
Efektywność 2
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.5 | · | 0.0 | 0.0 | 0.0 | · | 0.0 | |
| Receivables Turnover | · | · | · | 0.0 | 0.0 | 0.0 | · | 0.0 | 0.0 | 168.5 | · | · | · | · | · | · |
Wycena (TTM) 10
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $0 | $0 | · | $0 | $20.0K | $16M | · | $16M | $16M | $16M | · | · | · | · | · | $0 | |
| Net Income TTM | $-7M | $-7M | · | $-8M | $-10M | $6M | · | $2M | $3M | $3M | · | $-15M | $-12M | $-13M | · | $-14M | |
| Market Cap | $12M | $8M | · | $10M | $10M | $9M | · | $11M | $12M | $167M | · | $39M | $40M | $58M | · | $60M | |
| P/E | -1.8 | -1.2 | · | -1.5 | -1.2 | 1.9 | · | -0.7 | -0.4 | -0.5 | · | -0.2 | -0.4 | -1.6 | · | -1.9 | |
| P/S | · | · | · | · | 494.4 | 0.6 | · | 0.7 | 0.8 | 10.4 | · | · | · | · | · | · | |
| P/B | 0.7 | 0.6 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 4.8 | · | 4.9 | 2.9 | 5.7 | · | 5.7 | |
| P / Tangible Book | 0.8 | 0.6 | · | 0.6 | 0.6 | 0.5 | · | 0.5 | 0.5 | 6.4 | · | · | 13.7 | · | · | · | |
| P / Cash Flow | · | -2.4 | · | · | · | -3.3 | · | · | · | 12.2 | · | · | · | -18.8 | · | · | |
| P / FCF | · | -2.4 | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Earnings Yield | -55.1% | -84.5% | · | -66.9% | -83.3% | 53.2% | · | -141.5% | -274.3% | -188.7% | · | -420.2% | -248.1% | -61.5% | · | -52.1% |
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
Rachunek zysków i strat
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Przychody | $0 | $16M | $0 | — | $0 |
| Marża Operacyjna % | — | 28.1% | — | — | — |
| Zysk netto | $-11M | $4M | $-13M | $-14M | $-14M |
| Rozwodniony EPS | $-2.64 | $0.87 | $-24.25 | $-18.55 | $-57.12 |
Bilans
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 6.0 | 4.9 | 2.9 | 2.3 | 5.6 |
| Wskaźnik Szybkości | 5.1 | 4.6 | 1.5 | 1.8 | 4.9 |
Przepływy pieniężne
| 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $-10M | $9M | — | $-10M | $-11M |
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
📊
Wybierz metryki, które są dla Ciebie ważne — kliknij ➕ obok dowolnego wiersza w Pełnych Fundamentach powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Właściciele instytucjonalni (13F) 23 emitenci · $2.7M łącznie · Na dzień 30 czerwca 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 12 (+8 vs poprzedni kw.) | 5 (-1 vs poprzedni kw.) | 3 (-1 vs poprzedni kw.) | 2 (+1 vs poprzedni kw.) | +789K |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| PERCEPTIVE ADVISORS LLC | $1 153 179 | 438 471 | 42,36% | Akcje |
| ADAR1 Capital Management, LLC | $441 685 | 167 941 | 16,22% | Akcje |
| CITADEL ADVISORS LLC | $305 109 | 116 011 | 11,21% | Akcje |
| TWO SIGMA INVESTMENTS, LP | $233 523 | 88 792 | 8,58% | Akcje |
| MILLENNIUM MANAGEMENT LLC | $195 151 | 74 202 | 7,17% | Akcje |
| RENAISSANCE TECHNOLOGIES LLC | $78 437 | 29 824 | 2,88% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $66 020 | 25 103 | 2,43% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $52 234 | 19 861 | 1,92% | Akcje |
| Scientech Research LLC | $49 302 | 18 746 | 1,81% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $34 269 | 13 030 | 1,26% | Akcje |
| LPL Financial LLC | $32 875 | 12 500 | 1,21% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $31 923 | 12 138 | 1,17% | Akcje |
| NORTHERN TRUST CORP | $16 314 | 6 203 | 0,60% | Akcje |
| JANE STREET GROUP, LLC | $15 157 | 5 763 | 0,56% | Akcje |
| UBS Group AG | $5 157 | 1 961 | 0,19% | Akcje |
| Caitong International Asset Management Co., Ltd | $4 768 | 1 813 | 0,18% | Akcje |
| MORGAN STANLEY | $3 703 | 1 408 | 0,14% | Akcje |
| Tower Research Capital LLC (TRC) | $2 201 | 837 | 0,08% | Akcje |
| SBI Securities Co., Ltd. | $673 | 256 | 0,02% | Akcje |
| VANGUARD GROUP INC | $394 | 200 | 0,01% | Akcje |
| HRT FINANCIAL LP | $154 | 58 612 | 0,01% | Akcje |
| BlackRock, Inc. | $153 | 58 | 0,01% | Akcje |
| Activest Wealth Management | $5 | 2 | 0,00% | Akcje |
Insiderzy spółki 28 insiderów · 9 dyrektorzy generalni · 13 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Brian M. Strem | President and CEO | 1 lipca 2026 F | 58 823 | 0 | 0 | $0 |
| Melissa Tosca | CFO | 1 lipca 2026 F | 26 064 | 0 | 0 | $0 |
| Sarah Romano | Chief Financial Officer | 10 lutego 2022 F | 22 746 | 0 | 0 | $0 |
| Ryan Randall Brenneman | Chief Financial Officer | 18 lipca 2016 A | — | 0 | 0 | $0 |
| Stephen From | Executive Chairman | 5 stycznia 2022 F | 67 693 | 0 | 0 | $0 |
| Brenda Mann | VP of Research & Development | 2 listopada 2021 F | 15 136 | 0 | 0 | $0 |
| MANZO MICHAEL P. | VP of Engineering | 3 sierpnia 2021 F | 15 378 | 0 | 0 | $0 |
| Barbara Wirostko | Chief Medical Officer | 6 sierpnia 2019 F | 403 893 | 0 | 0 | $0 |
| Michael Garanzini | Chief Commercial Officer | 10 lipca 2018 A | 196 250 | 0 | 0 | $0 |
| Erin Parsons | Dyrektor | 10 czerwca 2026 A | 5 260 | 0 | 0 | $0 |
| Carmine N. Stengone | Dyrektor | 10 czerwca 2026 A | 1 250 | 0 | 0 | $0 |
| Aron Shapiro | Dyrektor | 10 czerwca 2026 A | 3 000 | 0 | 0 | $0 |
| David Hollander | Dyrektor | 10 czerwca 2026 A | — | 0 | 0 | $0 |
| Lisa Walters-Hoffert | Dyrektor | 10 czerwca 2026 A | 1 250 | 0 | 0 | $0 |
| Praveen Tyle | Dyrektor | 10 czerwca 2026 A | 5 014 | 0 | 0 | $0 |
| Morton Goldberg | Dyrektor | 1 lutego 2021 A | 0 | 0 | 0 | $0 |
| Thomas Hancock | Dyrektor | 1 lutego 2021 A | 13 487 | 0 | 0 | $0 |
| Peter Greenleaf | Dyrektor | 1 lutego 2019 A | — | 0 | 0 | $0 |
| Thomas Balland | Dyrektor | 21 czerwca 2017 A | 10 422 | 0 | 0 | $0 |
| Mounia Chaoui | Dyrektor | 29 marca 2016 A | 10 422 | 0 | 0 | $0 |
| Ventech Capital II | Posiadacz 10% | 13 marca 2017 S | 1 431 814 | 0 | 0 | $0 |
| NATIXIS PRIVATE EQUITY | Posiadacz 10% | 19 lutego 2015 C | 674 205 | 0 | 0 | $0 |
| IPSA (INNOVEN PARTENAIRES S.A.) | Posiadacz 10% | 19 lutego 2015 C | 1 460 479 | 0 | 0 | $0 |
| Eric Joseph Daniels | — | 1 kwietnia 2026 F | 31 741 | 0 | 0 | $0 |
| Kenneth L Gayron | — | 29 września 2023 A | — | 0 | 0 | $0 |
| Paul G Chaney | — | 3 marca 2023 A | 91 229 | 0 | 0 | $0 |
| Franz Obermayr | — | 1 lutego 2021 A | — | 0 | 0 | $0 |
| Bernard Malfroy-Camine | — | 1 lutego 2021 A | 61 525 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Aktywiści i właściciele 5%+ 5 akcji
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Armistice Capital, LLC, Steven Boyd ×10 zgłoszenia | 3 sierpnia 2021 | — | Pierwotne zgłoszenie | Kampania zarządu | SEC |
| IPSA (formerly Innoven Partenaires S.A.), FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Capital 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI La Banque Postale Innovation 1, Jean-Michel Paulhac ×3 zgłoszenia | 17 stycznia 2018 | — | Pierwotne zgłoszenie | — | SEC |
| FCPR Ventech A, FCPR Ventech B, FCPR Ventech Coinvest, FCPR Ventech Capital II, Alain Caffi, Jean Bourcereau ×2 zgłoszenia | 16 czerwca 2017 | — | Pierwotne zgłoszenie | — | SEC |
| Innoven Partenaires S.A. (IPSA), Innoven 2002 FCPI N°6, Innoven 2003 FCPI N°7, FCPI Innoven Europe, FCPI Innoven Europe 2, FCPI Innoven Europe 3, FCPI Innoven Capital, FCPI Innoven Capital 2, FCPI Poste Innovation, FCPI Poste Innovation 2, FCPI Poste Innovation 3, FCPI Poste Innovation 5, FCPI Poste Innovation 6, FCPI Poste Innovation 9, FCPI La Banque Postale Innovation 1, Jean-Michel Paulhac, Thomas Balland ×2 zgłoszenia | 16 czerwca 2017 | — | Pierwotne zgłoszenie | — | SEC |
| Stephen From | 4 marca 2015 | — | Pierwotne zgłoszenie | — | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Posiadanie ETF-ów Posiadane przez 1 fundusz ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0,00% | 19 861 SH | 8 sierpnia 2026 | Dziennie |